Search Results

You searched for : HSCT

	Startups that make life of Thalassemia patients easier â€“ Special Feature on World Thalassemia Day - 8th May Thalassemia is a preventable genetic blood disorder in which the patient's body cannot make sufficient red blood cells (RBC) on its own and require ... May 07
	Lupin Launches Posaconazole Delayed-Release Tablets Lupin & its AET Pharma US Inc. (part of Tiefenbacher Group) received an approval for its ANDA from the USFDA... Feb 17
	First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT) Orca Bio, today announced the first clinical data from its first-generation investigational therapy,... Dec 07
	New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
	Merck received US FDA approval for Keytruda FDA approves expanded indication for Merckâ€™s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
	FDA Approves Expanded Indication for Merckâ€™s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	Stem Cell therapy has long lasting Neurological benefits Researchers show that stem cell therapy has a better and long-lasting effect on Neurological disorders.... Mar 19
7 Matching result(s) found!

-Advertisements-

Trending Now
	The Role of Hormones in Obesity: Why Men and Women Gain Weight DifferentlyJune 12, 2024
	Silent Killer: How a Young Mother’s Vision Loss Led to a Lung Cancer DiagnosisJune 12, 2024
	TruAlt Bioenergy’s subsidiary, Leafiniti Bioenergy supplies over 1000 tons of Compressed Biogas to AG&P Pratham in just 5 monthsJune 11, 2024
	Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in SingaporeJune 11, 2024
	Poor Muscle Health in Obesity Can be A Major Risk Factor for Early DeathJune 11, 2024
	Machine Learning Uncovers How Organ Ageing Impacts Health and LongevityJune 11, 2024
	Why Education is Essential for Health and LongevityJune 11, 2024
	New Study Reveals Antidepressant Withdrawal Symptoms Less Common but Still SignificantJune 10, 2024
	Why Lowering Salt Intake Might Help Your Skin: Key Findings from UCSF StudyJune 10, 2024
	Exploring AI's Potential: I&B Ministry's Seminar on Jobs and Healthcare AdvancementsJune 10, 2024
	Deeply saddened by the passing away of Sri Ramoji Rao GaruJune 08, 2024
	Surmandal and Telangana Tourism to present Hindustani Classical recital at JNAFAUJune 08, 2024
	Join CA Rahul Malodia in Rajkot for the ‘Vyapari to CEO’ Transformational WorkshopJune 08, 2024
	Right diagnostic test and right treatment at the right time can prevent antimicrobial resistanceJune 08, 2024
	Harnessing the Power of Yoga: I&B Ministry's Campaign for International Day of Yoga 2024June 08, 2024
	Guarding Little Minds: Omega-3 Emulsion Shields Newborn BrainsJune 08, 2024
	Laughter-Induced Syncope: When a Chuckle Turns SeriousJune 08, 2024
	Latest Research Highlights The Role of Liver Glucose Production in Type 2 DiabetesJune 08, 2024
	Ayushman Bharat Expansion: Bihar's Ambitious Health Card InitiativeJune 08, 2024
	Nashik Hosts Successful ‘Frontiers In Onco-Surgery’ Conference At HCGMCC, Drawing Oncologists NationwideJune 07, 2024

Search Results

Startups that make life of Thalassemia patients easier â€“ Special Feature on World Thalassemia Day - 8th May

Lupin Launches Posaconazole Delayed-Release Tablets

First Clinical Data from Ongoing Orca-T Trial Shows Significantly Improved 12-Month Graft Versus Host Disease (GvHD)-Free and Relapse-Free Survival (GRFS) in Blood Cancer Patients Receiving a Hematopoietic Stem Cell Transplant (HSCT)

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Merck received US FDA approval for Keytruda

FDA Approves Expanded Indication for Merckâ€™s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL)

Stem Cell therapy has long lasting Neurological benefits

Trending Now